Conclusion: SP1 was associated with lymph node metastasis, TNM stage and depth of invasion, and indicated poor clinical outcome, which brought new insights on the potential candidacy of SP1 in clinical usage. Here, SP1 is linked to metastatic malignant neoplasm in the lymph nodes.